BioWorld

July 24, 2002

View Archived Issues

Bayer Buying Pharmacogenomics Firm Visible Genetics For $61.4M

Bayer Corp. is scooping up Visible Genetics Inc. for $61.4 million in cash as the parties signed a definitive agreement for a deal that brings to Bayer VGI's Trugene HIV-1 Genotyping Kit and OpenGene DNA Sequencing System. (Bioworld Today) Read More

ICOS, Texas Biotechnology Stop Phase IIb/III Extension

Read More

Microarray Profiling Reveals Gene Dots Connecting Lung Carcinoma, Tumor Excision, Odds On Survival

Read More

Corvas Cuts 40 Percent Of Staff, Focuses On Late-Stage Products

Read More

Other News To Note

Read More

U.S. Patent Disclosures

Read More